Advertisment

Indian Journal of Nephrology About us |  Subscription |  e-Alerts  | Feedback | Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Current Issue | Archives| Ahead of print | Search |Instructions |  Editorial Board  

Users Online:4008

Official publication of the Indian Society of Nephrology
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

Serum catalytic Iron: A novel biomarker for coronary artery disease in patients on maintenance hemodialysis

Rajapurkar M M, Lele S S, Malavade T S, Kansara M R, Hegde U N, Gohel K D, Gang S D, Shah S V, Mukhopadhyay B N

Year : 2013| Volume: 23| Issue : 5 | Page no: 332-337

   This article has been cited by
 
1 Deferiprone: A Forty-Year-Old Multi-Targeting Drug with Possible Activity against COVID-19 and Diseases of Similar Symptomatology
George J. Kontoghiorghes
International Journal of Molecular Sciences. 2022; 23(12): 6735
[Pubmed]  [Google Scholar] [DOI]
2 Increased serum catalytic iron may mediate tissue injury and death in patients with COVID-19
Vipul Chakurkar, Mohan Rajapurkar, Suhas Lele, Banibrata Mukhopadhyay, Valentine Lobo, Ramakrishna Injarapu, Muddassir Sheikh, Bharatkumar Dholu, Arpita Ghosh, Vivekanand Jha
Scientific Reports. 2021; 11(1)
[Pubmed]  [Google Scholar] [DOI]
3 Recent Advances in Understanding the Pathogenesis of Atherosclerosis in CKD Patients
Sudhir V. Shah,Ashutosh M. Shukla,Chhanda Bose,Alexei G. Basnakian,Mohan Rajapurkar
Journal of Renal Nutrition. 2015;
[Pubmed]  [Google Scholar] [DOI]

 

Indian Journal of Nephrology
Published by Wolters Kluwer - Medknow
Online since 20th Sept '07